Sign up for our Newsletter!
IPN in the Media
Our media hub features a collection of articles and podcasts that highlight the innovative work of the IPN. Explore insights from our faculty and partners as they discuss the latest research and developments in the field of psychedelics and neurotherapeutics. Stay informed on how our institute is shaping the future of mental health.
Why it's hard to study the neuroscience of psychedelics
A 3-part podcast discussing the breadth of psychedelic research today, ketamine use during cancer treatment, and next-gen psychedelics without "the trip."
NPR's Short Wave on April 7-9, 2025
We Need Trip-Free Psychedelics in Medicine
Scientists are on the brink of developing treatments for Alzheimer’s Disease, chronic pain, traumatic brain injuries, and more with trip-free psychedelic molecules.
From DoubleBlind Magazine on December 05, 2024
Psychedelics (Minus the Trip) Could Provide Powerful Anxiety Relief
Separating the anti-anxiety effects from the hallucinogenic effects of psychedelic drugs could be a game-changer for anxiety relief.
Vice - November 22, 2024
Neuroplasticity and Psychedelics with Dr. John Gray
Audible River Podcast
September 11, 2024
Luminous: Is it the drug or is it the trip?
To The Best of Our Knowledge
Wisconsin Public Radio - December 16, 2023
New psychedelic-like drugs: All treatment, no trip?
by Lisa M. Krieger
Mercury News - December 12, 2023
As Americans accept marijuana, use of LSD and other psychedelic drugs as medicine could also grow
by Gretchen Cuda Kroen
Cleveland News - November 19, 2023
Do You Need to 'Trip' for Psychedelics to Work as Medicine?
by Rachel Nuwer
Scientific American - November 8, 2023
What If Psychedelics’ Hallucinations Are Just a Side Effect?
by Richard A. Friedman
The Atlantic - November 8, 2023
Psychedelic treatments are speeding towards approval — but no one knows how they work
by Sara Reardon
Nature - November 1, 2023
The firms hoping to take psychedelic drugs mainstream
by Zoe Corbyn
BBC - September 15, 2023
Engineering non-hallucinogenic psychedelics: 5 Questions for researcher David Olson
by Jane C. Hu
The Microdose -September 11, 2023
Lifting depression: Are hallucinations compulsory?
by Rachel Williamson
Cosmos Magazine - August 7, 2023
Could psychedelic therapy be the next frontier for mental health care in California?
by Maggie Angst
Sacramento Bee - August 1, 2023
Psychedelics might revolutionize therapy. What happens if you remove the trip?
by Oshan Jarow
Vox - July 25, 2023
Cracking the chemical code
by Will Brendza
Boulder Weekly - June 29, 2023
Psychedelics May Reopen Locked Learning Opportunities
by Andrew Meissen
Lucid News - June 22, 2023
Delix Therapeutics Announces Completion of 1st Cohort Dosing, Dose Escalation Approval in Phase I Trial for Novel Compound DLX-001
by Delix Therapeutics
PR Newswire - June 20, 2023
LSD and Magic Mushrooms Dramatically Rewire the Brain, New Study Reveals
by Miriam Fauzia
Inverse - June 6, 2023
Delix Therapeutics starts clinical trial of non-hallucinatory psychedelic drug based on UC Davis research
by Mark Anderson
Sacramento Inno - May 17, 2023
They discover how psychedelics penetrate neurons to fight mental illness
National World News - April 23, 2023
How psychedelic drugs may help with depression
by Sharon Reynolds
NIH Research Matters - March 14, 2023
Understanding psychedelic antidepressant action
by Sarah Crunkhorn
Nature - March 7, 2023
Study Demonstrates Mechanism of Psychedelic-Induced Neuroplasticity
Alana Hippensteele
Pharmacy Times - March 7, 2023
Breakthrough study discovers that psychedelics breach our neurons
by B. Davis Zarley
Freethink - March 2, 2023
This is your brain on psychedelics
by Erin Schumaker, Ben Leonard and Ruth Reader
Politico - February 27, 2023
Psychedelics Slip Past Cell Membranes When Treating Depression
by Alejandra Manjarrez
The Scientist - February 24, 2023
How psychedelic compounds stimulate neuronal growth
by Shi En Kim
C&E News - February 22, 2023
New research illuminates how the human brain creates its own psychedelic drugs
by Troy Farah
Salon - February 20, 2023
New Study Shows SSRIs Ineffective Compared to Psychedelics
by Jason Najum
Microdose - February 17, 2023
New mechanism proposed for why some psychedelics act as antidepressants
by John Timmer
ARS Technica - February 17, 2023
Delix: Elucidating How Psychedelics Actually Induce Neuroplasticity Vs. SSRIs
by Lara Golstein
Benzinga - February 17, 2023
Therapeutic Effects of Psychedelic Drugs May Depend on Receptor Location, Study Suggests
Genetic Engineering & Biotechnology News - February 17, 2023
Lipophilicity helps explain psychedelic drugs’ therapeutic effects
by Jamie Durrani
Chemistry World - February 17, 2023
What's new in psychedelics research
Politico Pulse Check Podcast
February 16, 2023
Descubren por que los alucinogenos tienen efectos conta la depresion
by Josep Corbella Barcelona
La Vanguardia - February 16, 2023
By getting inside nerve cells, psychedelics might improve mental health
by Sam Friedberg
List 23 - February 16, 2023
Receptor Location Matters for Psychedelic Drug Effects
Neuroscience News - February 16, 2023
This Is What Could Make Psychedelic Drugs More Powerful – The Key to Rebuild Neural Connections And Treat Mental Illness
by Kamal Saini
Revyuh Media - February 16, 2023
Psychedelic drug effects: An inside job?
by Anette Breindl
BioWorld - February 16, 2023
A New Mechanism of Psychedelic Action in the Brain Has Been Discovered
by Ruairi Mackenzie
Technology Networks - February 16, 2023
Psychedelics may improve mental health by getting inside nerve cells
by McKenzie Prillaman
Science News - February 16, 2023
Turn on, tune in to psychedelics’ benefits
by Erin Schumaker, Ruth Reader and Ben Leonard
Politico - February 14, 2023
UCD’s psychedelics institute came at the right time
by Monica Stark
Davis Enterprise - February 10, 2023
US Universities Ride The Psychedelics Wave With New Programs In Their Medical Schools
by Lara Goldstein
Benzinga - February 6, 2023
UC Davis Launches Institute for Psychedelics and Neurotherapeutics
by Thomas Edward
High Times - February 3, 2023
UC Davis announces new institute to study psychedelics
by Dina Kupper
CBS News - February 2, 2023
Co-founder of Boston biotech will lead California psychedelic medical institute
by Mark Anderson
Boston Business Journal - February 2, 2023
UC Davis funds psychedelic medical institute
by Mark Anderson
Sacramento Inno - February 02, 2023
The psychedelic ibogaine can treat addiction. The race is on to cash in
by Kaitlin Sullivan
The Guardian - January 24, 2023
Meet the Team Who Want To Develop Psychedelics Without the Hallucinations
by Ruairi Mackenzie
Technology Networks - December 19, 2022
Drug Companies Join Medical Psychedelic Movement—but Without the High
by Daniela Hernandez and Brianna Abbott
The Wall Street Journal - December 18, 2022
Transforming Psychedelics into Approved Medicines
by Kathy Vuksanaj
Genetic Engineering and Biotechnology News - October 6, 2022
LSD variant cures depression in mice without making them trip: study
by Jesse O'Neill
New York Post - October 5, 2022
LSD-like compounds may have antidepressant effect without hallucinations
by Deep Shukla
Medical News Today - October 4, 2022
A drug based on LSD appears to treat depression in mice without the psychedelic trip
by Jon Hamilton
NPR - September 28, 2022
Virtual drug screening identifies possible new antidepressants in LSD-like molecules
by Meghana Keshavan
STAT News - September 28, 2022
Taking the tripping out of psychedelic medicine
by Elie Dolgin
Nature - September 28, 2022
How psychedelics could fix the brain
by Babbage
The Economist - September 27, 2022
Ketamine, psilocybin and ecstasy are coming to the medicine cabinet
The Economist - September 21, 2022
Delix Therapeutics : psychedelics without the trip
by Ken Garber
Nature - August 19, 2022
The Psychedelic Industry's Next Hurdle Is How to Go Mainstream
by Kristen V Brown
Bloomberg - July 25, 2022
Taking the Magic Out of Magic Mushrooms
by Dana Smith
New York Times - July 15, 2022
Changing Minds
By Andy Fell
UC Davis Magazine - June 6, 2022
Wellness: Ketaminels Ketamine the next big thing is psychiatric therapy?
by Mark Billingsley
Sacramento Magazine - April 20, 2022
Research on mice that ‘sweat out’ fat wins STAT Madness for University of Pennsylvania
by Maddie Bender
STAT News - April 4, 2022
Drug companies are investing big in psychedelics, but can they engineer out the trip?
by Bethany Halford
C&E News - March 6, 2022
Relieving depression with LSD-like drugs without causing hallucinations
by Angus Liu
Fierce Biotech - January 31, 2022
No hallucinations? LSD relatives appear to treat depression in mice, without obvious side effects
by Robert Service
Science - January 27, 2022
Hallucinogen chemistry guides antidepressant drug discovery
by Bethany Halford
C&E News - January 27, 2022
The Future of Psychedelic Medicine Will Be Drugs You’ve Never Heard Of
by Shayla Love
Vice - January 24, 2022
The Promises and Perils of Psychedelic Health Care
by Kat Eschner
New York Times - January 5, 2022
Harnessing Psychedelics for Healing
by Jesse Kathan
Comstock's Magazine - December 13, 2021
Sacramento Region Innovation Awards: Delix Therapeutics explores psychedelics for use in brain therapy
by Mark Anderson
Sacramento Inno - November 19, 2021
Delix Therapeutics Pursues A Psychedelic-Inspired Medicine Without The Trip
by Will Yakowicz
Forbes - October 1, 2021
UC Davis psychedelics startup Delix Therapeutics raises $70 million for clinical trials
by Mark Anderson
Sacramento Business Journal - September 27, 2021
Delix raises $70 million to synthesize psychedelic-inspired drugs
by Ryan Cross
C&E News - September 27, 2021
A new psychedelics player emerges to treat mental health disorders — minus the hallucinogenic effects
by Nicole DeFeudis
Endpoints News September 27, 2021
Startup Raises Money for Psychedelics Without a Trip
by Tiffany Kary
Bloomberg - September 27, 2021
Delix raises $70M to test psychedelic analogs for treating brain disorders in clinical trials next year
by Kyle LaHucik
Fierce Biotech - September 27, 2021
Fierce Biotech's 2021 Fierce 15
by Ben Adams
Fierce Biotech - September 27, 2021
Move Over, Psilocybin And Ketamine: A New Compound Derived From A Naturally-Growing Hallucinogen May Revolutionize Psychiatry
by Rebecca Coffey
Forbes - June 23, 2021
Can we take the high out of psychedelics?
by Grace Brown
Wired - June 6, 2021
Biosensor advances drug discovery
by Brian Doctrow
NIH Research Matters - May 11, 2021
How Psychedelics Without Hallucinogenic Effects Could Revolutionize Psychiatry
by Naton Ponieman
Benziga - May 7, 2021
Sensor sheds light on hallucinogenic activity
by Alla Katsnelson
C&E News - April 29, 2021
Psychedelic drugs without the trip? This sensor could help seek them out
by Ariana Remmel
Nature - April 29, 2021
Non-hallucinogenic psychedelics: scientists close in on compound
by Natalie Grover
The Guardian - April 28, 2021
Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction
by Mandy Oaklander
Time - April 5, 2021
A Safer Psychedelic
Bio Eats World - January 21, 2021
Psychedelic derivative dampens addiction
by Katie Kingwell
Nature - December 17, 2020
Progress Toward A Safer Psychedelic Drug To Treat Depression And Addiction
by Jon Hamilton
NPR - December 9, 2020
Ibogaine inspires potential neuropsychiatric treatment
by Bethany Halford
C&E News - December 9, 2020
Chemists re-engineer a psychedelic to treat depression and addiction in rodents
by Robert F. Service
Science - December 9, 2020
Psychedelics re-engineered for potential use in the clinic
by Gabriela Manzano-Nieves & Conor Liston
Nature - December 9, 2020
Can psychedelic drugs treat depression?
Al Jazeera - March 20, 2019
A New Chapter in the Science of Psychedelic Microdosing
by Haley Weiss
The Atlantic - March 5, 2019
For Babies, Life May Be a Trip
by Alison Gopnik
The Wall Street Journal - July 18, 2018
Psychedelics forge connections between neurons
by Cici Zhang
C&E News - June 13, 2018
LSD and DMT Caused the Brain to Form New Connections in Flies and Rats
by Daniel Oberhaus
Vice - June 12, 2018
Psychedelic drugs change brain cells in ways that could help fight depression, addiction and more
by Melissa Healy
Los Angeles Times - June 12, 2018
LSD and magic mushrooms could heal damaged brain cells in people suffering from depression, study shows
by Alex Matthews-King
The Independent - June 12, 2018
Psychedelic Drugs May Help the Brain Repair Itself, Study Finds
by Ed Cara
Gizmodo - June 12, 2018